Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2008-9-4
pubmed:abstractText
During uncontrolled HIV disease, both TNF-related apoptosis inducing ligand (TRAIL) and TRAIL receptor expression are increased. Enhanced TRAIL sensitivity is due to TRAIL receptor up-regulation induced by gp120. As a result of successful antiretroviral therapy TRAIL is down-regulated, and there are fewer TRAIL-sensitive cells. In this setting, we hypothesized that all cells that contain virus, including those productively- and latently-infected, have necessarily been "primed" by gp120 and remain TRAIL-sensitive, whereas uninfected cells remain relatively TRAIL-resistant.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-10802713, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-11238596, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-11283636, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-11385301, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-11602752, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-11745330, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-15141001, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-15573381, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-15990565, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-16632604, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-16638878, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-17056552, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-17112786, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-17177302, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-17356300, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-17403612, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-17437073, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-17705184, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-17907802, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-8523526, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-8996241, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-9144289, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-9360927, http://linkedlifedata.com/resource/pubmed/commentcorrection/18769477-9671771
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1932-6203
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e3096
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Beneficial effect of TRAIL on HIV burden, without detectable immune consequences.
pubmed:affiliation
Mayo Clinic, Rochester, Minnesota, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural